Clinical Trials Logo

Clinical Trial Summary

This article describes a case of successful treatment of a 59-year-old man with sepsis as a result of periprosthetic infection against the background of severe SARS-CoV-2-19, who was hospitalized for 59 days, 57 of which were in the intensive care unit. Vibroacoustic pulmonary therapy, the concept of noninvasive ventilation, syndrome therapy, combination antibiotic therapy taking into account the pathogen and antibiotic sensitivity were used in the treatment.

Clinical Trial Description

During the pandemic caused by SARS-CoV-2-19, the whole world faced difficulties. Nevertheless, surgeons had to perform surgical treatment for patients who needed immediate help with a confirmed coronavirus infection [1, 2, 3]. Periprosthetic joint infection is a severe and undesirable consequence after arthroplasty [4, 5]. Patients with coronavirus infection and bacterial infection correlate with an unfavorable outcome [6, 7, 8] The effect of vibroacoustic therapy in the treatment of various conditions has not been sufficiently studied [9, 10]. This clinical case describes the complex therapy of a patient with a periprosthetic infection on the background of SARS-CoV-2 using a vibroacoustic pulmonary device. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT05188482
Study type Observational [Patient Registry]
Source Astana Medical University
Status Completed
Start date September 29, 2020
Completion date January 1, 2021